Is GBL legal in Malaysia?

Legal status

GBL is not named, and it does not need to be. «Gamma hydroxybutyric acid (GHB)» is named in Part III of the First Schedule to the Dangerous Drugs Act 1952, and gamma-butyrolactone is the lactone of that acid, which is to say its intramolecular ester. Part III provides: «The esters and ethers, unless appearing in another Part, of the drugs in this Schedule whenever the existence of such esters or ethers is possible». An ester is a named relationship rather than a resemblance judgment, so GBL reads onto the clause on the face of the words. No Malaysian decision applying the ester clause to GBL was found, so the reading is stated with its basis rather than asserted as settled practice.

Consequences if caught

Capital and life exposure. Gamma-butyrolactone is in the First Schedule, so section 39B reaches it and the death penalty is available. The chain is short and it does not pass through any weight: section 2 defines «dangerous drug» as «any drug or substance which is for the time being comprised in the First Schedule», section 39B(1) prohibits trafficking in «a dangerous drug», and section 39B(2) sets the penalty. And «trafficking» is defined in section 2 and it is far wider than selling: it «includes the doing of any of the following acts, that is to say, manufacturing, importing, exporting, keeping, concealing, buying, selling, giving, receiving, storing, administering, transporting, carrying, sending, delivering, procuring, supplying or distributing any dangerous drug otherwise than under the authority of this Act or the regulations made under the Act». Keeping, carrying and storing are on that list. This substance has NO section 37(da) presumption weight, and that is the thing most readers get backwards. Section 37(da) runs to twenty seven subparagraphs and names twenty three substances in all: nine opiate, cocaine, cannabis and opium entries at (i) to (x), fourteen amphetamine-type substances at (xi) to (xxiv), and four combination clauses. It does one thing: it presumes trafficking «until the contrary is proved» once a person is found in possession of at least the stated weight. It does NOT create the capital offence and it is not a threshold below which section 39B stops applying. Section 39B(1) prohibits trafficking in «a dangerous drug», full stop. So the absence of a weight means the prosecution has to prove trafficking rather than presume it from the quantity alone, and nothing more than that. Death is no longer mandatory and the change has two dates. Section 39B(2) once read simply «on conviction with death». The Dangerous Drugs (Amendment) Act 2017, Act A1558, in force 15 March 2018, opened a narrow gate out of it. The Abolition of Mandatory Death Penalty Act 2023, Act 846, in force 4 July 2023, then took the gate away by deleting subsections (2A) and (2B), because the discretion no longer needed a gate. Section 39B(2) now reads, in full: «Any person who contravenes any of the provisions of subsection (1) shall be guilty of an offence against this Act and shall be punished on conviction with death or imprisonment for life and shall, if he is not sentenced to death, be punished with whipping of not less than twelve strokes.» So the court chooses between death and imprisonment for life, with no precondition, and whipping of at least twelve strokes follows any sentence that is not death. The twelve is itself new: Act 846 substituted it for fifteen. The alternative to death is imprisonment for life, and it is worth being exact about that because Act 846 is widely described as replacing life with a term of thirty to forty years. It did that in the Penal Code, the Firearms Act, the Arms Act, the Kidnapping Act, the Strategic Trade Act and the Criminal Procedure Code. It did NOT do it in the Dangerous Drugs Act. Section 54 of Act 846 is the whole of what it does here: it substitutes twelve strokes for fifteen in section 39B(2) and deletes subsections (2A) and (2B). The words «imprisonment for life» in section 39B(2) are untouched, and no definition of that phrase appears anywhere in the Dangerous Drugs Act, so no year figure is stated in this cell. Two procedural consequences follow automatically. Section 41 removes a section 39B charge from the Sessions and Magistrates' Courts, so it is tried in the High Court. Section 41B(1) provides that bail «shall not be granted» where the offence is punishable with death, and also where it is punishable with more than five years. Section 39C escalates for a person with prior admissions or convictions under the consumption and possession provisions, to five to seven years with up to three strokes for the first escalation.

If prescribed or medical

There is no prescription route for GBL in Malaysia, and this cell states that rather than leaving a reader to infer it. Every prohibition in the Dangerous Drugs Act 1952, and the definition of trafficking in section 2, is qualified by the words «otherwise than under the authority of this Act or the regulations made under the Act», so a lawful holding is one that sits inside an authority granted under the Act. The authority the Act contemplates is a licence or a regulation made under it, and here there is nothing for one to attach to. It is reached at Part III of the First Schedule: it is the lactone, which is to say the intramolecular ester, of GHB, and Part III provides that «The esters and ethers, unless appearing in another Part, of the drugs in this Schedule whenever the existence of such esters or ethers is possible» are included. Neither Act evidences a registered product containing it. No Malaysian decision applying the ester clause to gamma-butyrolactone was found, so the reading is stated with its basis rather than as settled practice. The Poisons List carries «Gamma Butyrolactone» as a separate entry. Gamma-butyrolactone is also an industrial solvent, and nothing in either Act creates a personal authorisation for it.

Documentation

There is no document to carry, because there is no lawful holding for a document to evidence. This cell says so plainly rather than leave a traveller looking for paperwork that does not exist for GBL. The entry that forecloses the question is «Gamma hydroxybutyric acid (GHB)», reached at Part III of the First Schedule. Section 25 of the Dangerous Drugs Act 1952, the traveller provision, turns on a medicinal preparation supplied by or on the prescription of a medical practitioner residing outside Malaysia, so it has nothing to attach to here. It is also confined to Part V of the Act, the external trade Part, and would not answer a possession charge even if it did apply. Getting the paperwork wrong is not a paperwork penalty. Section 37(d) provides that «any person who is found to have had in his custody or under his control anything whatsoever containing any dangerous drug shall, until the contrary is proved, be deemed to have been in possession of such drug and shall, until the contrary is proved, be deemed to have known the nature of such drug», and section 37(da) can then presume trafficking from the weight of the material alone. A foreign prescription, a licence issued in another country, and religious or traditional use are none of them provided for anywhere in the Act.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Malaysia’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.